Skip to main content

Table 1 Characteristics and Endpoint definitions of included randomized trials

From: Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs

Study

Year

Location

Number

Study design

Primary endpoint

Definition of TLF

Definition of ST

Follow up (months)

Lost to FU (%)

AIDA

2017

Multicenter

1845

RCT

TVF

Cardiac

death,

TVMI,

ID-TLR

ARC

24

2.8

ABSORB III

2017

Multicenter

2008

RCT

TLF

Cardiac

death,

TVMI,

ID-TLR

ARC

24

2.1

ABSORB China

2016

Multicenter

480

RCT

IS-LL

Cardiac

death,

TVMI,

ID-TLR

ARC

24

3.7

ABSORB II

2016

Multicenter

501

RCT

Vasomotion, MLD

Cardiac

death,

TVMI,

ID-TLR

ARC

24

4.2

ABSORB Japan

2016

Multicenter

400

RCT

TLF

Cardiac

death,

TVMI,

ID-TLR

ARC

24

3

  1. Abbreviations: TLF target lesion failure, TVF target vessel failure, IS-LL in-segment late loss, MLD minimal lumen diameter, TVMI target vessel myocardial infarction, ID-TLR ischemia driven target lesion revascularization, RCT randomized clinical trials